SpineGuard SA (ALSGD.PA)
EUR 0.23
(-1.09%)
EUR 0.23
(-1.09%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -3.97 Million EUR | -116.3% |
| 2022 | -1.81 Million EUR | -30.99% |
| 2021 | -1.38 Million EUR | -20.76% |
| 2020 | -1.14 Million EUR | -267.95% |
| 2019 | -311.37 Thousand EUR | 70.98% |
| 2018 | -1.07 Million EUR | 57.87% |
| 2017 | -2.54 Million EUR | 29.91% |
| 2016 | -3.63 Million EUR | 8.58% |
| 2015 | -3.97 Million EUR | 11.27% |
| 2014 | -4.47 Million EUR | -42.07% |
| 2013 | -3.15 Million EUR | 1.15% |
| 2012 | -3.18 Million EUR | -22.16% |
| 2011 | -2.61 Million EUR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -1.61 Million EUR | 0.0% |
| 2023 Q4 | -2 Million EUR | 0.0% |
| 2023 FY | -3.92 Million EUR | -116.3% |
| 2023 Q2 | -1.94 Million EUR | 0.0% |
| 2022 Q2 | -997.71 Thousand EUR | 0.0% |
| 2022 Q4 | -814.61 Thousand EUR | 0.0% |
| 2022 FY | -1.81 Million EUR | -30.99% |
| 2021 Q2 | -767.35 Thousand EUR | 0.0% |
| 2021 FY | -1.38 Million EUR | -20.76% |
| 2021 Q4 | -616.22 Thousand EUR | 0.0% |
| 2020 Q2 | -623.71 Thousand EUR | 0.0% |
| 2020 FY | -1.14 Million EUR | -267.95% |
| 2020 Q4 | -522 Thousand EUR | 0.0% |
| 2019 Q2 | -408.76 Thousand EUR | 0.0% |
| 2019 FY | -311.37 Thousand EUR | 70.98% |
| 2019 Q4 | 33.19 Thousand EUR | 0.0% |
| 2018 FY | -1.07 Million EUR | 57.87% |
| 2018 Q2 | -838.74 Thousand EUR | 0.0% |
| 2018 Q4 | -234.18 Thousand EUR | 0.0% |
| 2017 FY | -2.54 Million EUR | 29.91% |
| 2017 Q2 | -1.52 Million EUR | 0.0% |
| 2017 Q4 | -1.02 Million EUR | 0.0% |
| 2016 FY | -3.63 Million EUR | 8.58% |
| 2016 Q2 | -2.21 Million EUR | 0.0% |
| 2016 Q4 | -1.42 Million EUR | 0.0% |
| 2015 Q4 | -1.64 Million EUR | 0.0% |
| 2015 Q2 | -2.33 Million EUR | 0.0% |
| 2015 FY | -3.97 Million EUR | 11.27% |
| 2014 Q4 | -2.15 Million EUR | 0.0% |
| 2014 Q2 | -2.32 Million EUR | 0.0% |
| 2014 FY | -4.47 Million EUR | -42.07% |
| 2013 Q4 | -1.6 Million EUR | 0.0% |
| 2013 FY | -3.15 Million EUR | 1.15% |
| 2013 Q2 | -1.54 Million EUR | 0.0% |
| 2012 Q1 | -814.67 Thousand EUR | 0.0% |
| 2012 Q2 | -814.67 Thousand EUR | 0.0% |
| 2012 Q3 | -814.67 Thousand EUR | 0.0% |
| 2012 FY | -3.18 Million EUR | -22.16% |
| 2012 Q4 | -809.2 Thousand EUR | 0.67% |
| 2011 Q2 | -641.75 Thousand EUR | 0.0% |
| 2011 Q1 | -641.75 Thousand EUR | 0.0% |
| 2011 Q3 | -641.75 Thousand EUR | 0.0% |
| 2011 Q4 | -814.67 Thousand EUR | -26.94% |
| 2011 FY | -2.61 Million EUR | 0.0% |
| 2010 Q4 | -641.75 Thousand EUR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Affluent Medical SA | -13.06 Million EUR | 69.569% |
| Bluelinea Société Anonyme | -1.61 Million EUR | -146.555% |
| Carmat SA | -52.51 Million EUR | 92.429% |
| Diagnostic Medical Systems S.A. | -2.26 Million EUR | -75.545% |
| Euromedis Groupe | -5.55 Million EUR | 28.451% |
| Eurobio Scientific Société anonyme | 10.14 Million EUR | 139.208% |
| Ikonisys S.A. | -2.19 Million EUR | -81.248% |
| Implanet S.A. | -6.15 Million EUR | 35.443% |
| Median Technologies SA | -23 Million EUR | 82.717% |
| Theraclion SA | -3.15 Million EUR | -26.065% |
| Euroapi S.A. | -234.3 Million EUR | 98.303% |
| Guerbet SA | 38.67 Million EUR | 110.282% |
| Ion Beam Applications SA | 5.09 Million EUR | 178.085% |
| Koninklijke Philips N.V. | -115 Million EUR | 96.543% |
| Sequana Medical NV | -29.49 Million EUR | 86.518% |